T50.B95 类别:需要更具体的编码 Adverse effect of other viral vaccines
ICD-10-CM T50.B95 identifies “Adverse effect of other viral vaccines” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
章节 19: Injury, poisoning and certain other consequences of external causes
编码说明
无额外说明。
上级编码说明
章节 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T50 · Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances
Seventh character1
The appropriate 7th character is to be added to each code from category T50
A — initial encounter
D — subsequent encounter
S — sequela
更具体的编码
官方索引引用
官方索引引用 (28)
Diplovax (1)
- Diplovax药物和化学物质
Hepatitis B (1)
- Hepatitis B › vaccine药物和化学物质
Influenza vaccine (1)
- Influenza vaccine药物和化学物质
Measles virus vaccine(attenuated) (1)
Meruvax (1)
- Meruvax药物和化学物质
Mumps (1)
- Mumps › vaccine药物和化学物质
Mumpsvax (1)
- Mumpsvax药物和化学物质
Orimune (1)
- Orimune药物和化学物质
Poliomyelitis vaccine (1)
- Poliomyelitis vaccine药物和化学物质
Rabies (1)
- Rabies › vaccine药物和化学物质
Rubella vaccine (1)
- Rubella vaccine药物和化学物质
Rubeola vaccine (1)
- Rubeola vaccine药物和化学物质
Synagis (1)
- Synagis药物和化学物质
Triple (1)
- Triple › vaccine › MMR药物和化学物质
Vaccine NEC (12)
- Vaccine NEC › influenza药物和化学物质
- Vaccine NEC › measles药物和化学物质
- Vaccine NEC › measles › with mumps and rubella药物和化学物质
- Vaccine NEC › mumps药物和化学物质
- Vaccine NEC › poliomyelitis药物和化学物质
- Vaccine NEC › poliovirus药物和化学物质
- Vaccine NEC › rabies药物和化学物质
- Vaccine NEC › respiratory syncytial virus药物和化学物质
- Vaccine NEC › rubella药物和化学物质
- Vaccine NEC › sabin oral药物和化学物质
- Vaccine NEC › viral NEC药物和化学物质
- Vaccine NEC › yellow fever药物和化学物质
Viral vaccine NEC (1)
- Viral vaccine NEC药物和化学物质
Yellow (1)
- Yellow › fever vaccine药物和化学物质
其他编码的引用 (1)
Use additional code · code, if applicable, for adverse effect of other viral vaccine (T50.B95-)
历史
编码历史
最近记录的变更 · FY2025 · 04-01
生效日期
- 上级说明变更
Adverse effect of other viral vaccines
类别 — 请选择更具体的编码
CDC/NCHS · FY2025 · 04-01所有版本 (19)
| 所有版本 | 生效日期 | 编码历史 |
|---|---|---|
| FY2016 | 2015-10-01 | 首次收录 |
| FY2017 | 2016-10-01 | 分类表无变更 |
| FY2018 | 2017-10-01 | 分类表无变更 |
| FY2019 | 2018-10-01 | 上级说明变更 |
| FY2020 | 2019-10-01 | 分类表无变更 |
| FY2020 · April | 2020-04-01 | 分类表无变更 |
| FY2021 | 2020-10-01 | 上级说明变更 |
| FY2021 · 01-01 | 2021-01-01 | 分类表无变更 |
| FY2022 | 2021-10-01 | 分类表无变更 |
| FY2022 · 04-01 | 2022-04-01 | 分类表无变更 |
| FY2023 | 2022-10-01 | 分类表无变更 |
| FY2023 · 04-01 | 2023-04-01 | 分类表无变更 |
| FY2024 | 2023-10-01 | 分类表无变更 |
| FY2024 · 04-01 | 2024-04-01 | 分类表无变更 |
| FY2025 | 2024-10-01 | 分类表无变更 |
| FY2025 · 04-01 | 2025-04-01 | 上级说明变更 |
| FY2026 | 2025-10-01 | 分类表无变更 |
| FY2026 · April | 2026-04-01 | 分类表无变更 |
| FY2027 | 2026-10-01 | 分类表无变更 |
浏览此类别中更具体的编码。 参考核验不能确定临床适用性,也不保证报销。